Researchers developed a technique to gain a deeper understanding of ribosome function and their cooperative behaviors.

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...

Vaxxas and CEPI advance US$ 4.8 million programme for needle-free thermostable mRNA vaccines: Cambridge, Massachusetts Friday, January 24, 2025, 14:00 Hrs [IST] Vaxxas, a clinical ...

From being a promising yet underexplored approach in the 1990s, mRNA therapeutics have evolved dramatically. The discovery of ...

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

Vaxxas has announced that the CEPI, has approved the progression of a $7.2 million program to develop heat-stable, ...

Where can researchers look for a beacon of hope amid trying times in the pharmaceutical industry? Read on for answers.

In trials at University College London Hospitals (UCLH), an ASO is being used to target the mutated gene that results in the ...

The global Oligonucleotide CDMO Market, valued at US$2.33 billion in 2023, is forecasted to grow at a robust CAGR of 21.8%, ...

The human genome encodes potentially thousands of tiny proteins that were previously overlooked. The search is on to find out ...